Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 216

1.

Intradermal DNA vaccination combined with dual CTLA-4 and PD-1 blockade provides robust tumor immunity in murine melanoma.

Kos S, Lopes A, Preat V, Cemazar M, Lampreht Tratar U, Ucakar B, Vanvarenberg K, Sersa G, Vandermeulen G.

PLoS One. 2019 May 31;14(5):e0217762. doi: 10.1371/journal.pone.0217762. eCollection 2019.

2.

Electrochemotherapy of superficial tumors - Current status:: Basic principles, operating procedures, shared indications, and emerging applications.

Campana LG, Miklavčič D, Bertino G, Marconato R, Valpione S, Imarisio I, Dieci MV, Granziera E, Cemazar M, Alaibac M, Sersa G.

Semin Oncol. 2019 Apr;46(2):173-191. doi: 10.1053/j.seminoncol.2019.04.002. Epub 2019 May 9. Review.

PMID:
31122761
3.

Large Liver Blood Vessels and Bile Ducts Are Not Damaged by Electrochemotherapy with Bleomycin in Pigs.

Zmuc J, Gasljevic G, Sersa G, Edhemovic I, Boc N, Seliskar A, Plavec T, Brloznik M, Milevoj N, Brecelj E, Kos B, Izlakar J, Jarm T, Snoj M, Stukelj M, Miklavcic D, Cemazar M.

Sci Rep. 2019 Mar 6;9(1):3649. doi: 10.1038/s41598-019-40395-y.

4.

Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts.

Zakelj MN, Prevc A, Kranjc S, Cemazar M, Todorovic V, Savarin M, Scancar J, Kosjek T, Groselj B, Strojan P, Sersa G.

Oncol Rep. 2019 Mar;41(3):1658-1668. doi: 10.3892/or.2019.6960. Epub 2019 Jan 9.

5.

Electrochemotherapy with cisplatin for the treatment of a non-operable cutaneous fibroma in a cockatiel (Nymphicus hollandicus).

Racnik J, Svara T, Zadravec M, Gombac M, Cemazar M, Sersa G, Tozon N.

N Z Vet J. 2019 May;67(3):155-158. doi: 10.1080/00480169.2018.1564393. Epub 2019 Feb 20. No abstract available.

PMID:
30626280
6.

Electrochemotherapy - Emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration.

Campana LG, Edhemovic I, Soden D, Perrone AM, Scarpa M, Campanacci L, Cemazar M, Valpione S, Miklavčič D, Mocellin S, Sieni E, Sersa G.

Eur J Surg Oncol. 2019 Feb;45(2):92-102. doi: 10.1016/j.ejso.2018.11.023. Epub 2018 Dec 1. Review.

PMID:
30528893
7.

A combination of electrochemotherapy, gene electrotransfer of plasmid encoding canine IL-12 and cytoreductive surgery in the treatment of canine oral malignant melanoma.

Milevoj N, Tratar UL, Nemec A, Brožič A, Žnidar K, Serša G, Čemažar M, Tozon N.

Res Vet Sci. 2019 Feb;122:40-49. doi: 10.1016/j.rvsc.2018.11.001. Epub 2018 Nov 12.

PMID:
30453179
8.

Ultrasonographic changes in the liver tumors as indicators of adequate tumor coverage with electric field for effective electrochemotherapy.

Boc N, Edhemovic I, Kos B, Music MM, Brecelj E, Trotovsek B, Bosnjak M, Djokic M, Miklavcic D, Cemazar M, Sersa G.

Radiol Oncol. 2018 Oct 18;52(4):383-391. doi: 10.2478/raon-2018-0041.

9.

Multiparametric High-Resolution MRI as a Tool for Mapping of Hypoxic Level in Tumors.

Serša I, Bajd F, Savarin M, Jesenko T, Čemažar M, Serša G.

Technol Cancer Res Treat. 2018 Jan 1;17:1533033818797066. doi: 10.1177/1533033818797066.

10.

Time-Dependent Finite Element Analysis of In Vivo Electrochemotherapy Treatment.

Pintar M, Langus J, Edhemović I, Brecelj E, Kranjc M, Sersa G, Šuštar T, Rodič T, Miklavčič D, Kotnik T, Kos B.

Technol Cancer Res Treat. 2018 Jan 1;17:1533033818790510. doi: 10.1177/1533033818790510.

11.

The General Explanation Method with NMR Spectroscopy Enables the Identification of Metabolite Profiles Specific for Normal and Tumor Cell Lines.

Pečnik K, Todorović V, Bošnjak M, Čemažar M, Kononenko I, Serša G, Plavec J.

Chembiochem. 2018 Oct 4;19(19):2066-2071. doi: 10.1002/cbic.201800392. Epub 2018 Sep 14.

12.

Connecting the in vitro and in vivo experiments in electrochemotherapy - a feasibility study modeling cisplatin transport in mouse melanoma using the dual-porosity model.

Dermol-Černe J, Vidmar J, Ščančar J, Uršič K, Serša G, Miklavčič D.

J Control Release. 2018 Sep 28;286:33-45. doi: 10.1016/j.jconrel.2018.07.021. Epub 2018 Jul 20.

PMID:
30016733
13.

Intravital Monitoring of Vasculature After Targeted Gene Therapy Alone or Combined With Tumor Irradiation.

Savarin M, Prevc A, Rzek M, Bosnjak M, Vojvodic I, Cemazar M, Jarm T, Sersa G.

Technol Cancer Res Treat. 2018 Jan 1;17:1533033818784208. doi: 10.1177/1533033818784208.

14.

Effect of calcium electroporation on tumour vasculature.

Staresinic B, Jesenko T, Kamensek U, Krog Frandsen S, Sersa G, Gehl J, Cemazar M.

Sci Rep. 2018 Jun 20;8(1):9412. doi: 10.1038/s41598-018-27728-z.

15.

Electrochemotherapy with cisplatin or bleomycin in head and neck squamous cell carcinoma: Improved effectiveness of cisplatin in HPV-positive tumors.

Prevc A, Niksic Zakelj M, Kranjc S, Cemazar M, Scancar J, Kosjek T, Strojan P, Sersa G.

Bioelectrochemistry. 2018 Oct;123:248-254. doi: 10.1016/j.bioelechem.2018.06.004. Epub 2018 Jun 6.

PMID:
29898433
16.

Dose-Modifying Factor of Radiation Therapy with Concurrent Cisplatin Treatment in HPV-Positive Squamous Cell Carcinoma: A Preclinical Study.

Prevc A, Kranjc S, Cemazar M, Todorovic V, Zegura B, Novak M, Filipic M, Flezar MS, Kirbis IS, Rotter A, Brozic A, Zakelj MN, Poljak M, Hosnjak L, Groselj B, Strojan P, Sersa G.

Radiat Res. 2018 Jun;189(6):644-651. doi: 10.1667/RR14984.1. Epub 2018 Apr 13.

PMID:
29652621
17.

Antitumor effect of antibiotic resistance gene-free plasmids encoding interleukin-12 in canine melanoma model.

Lampreht Tratar U, Kos S, Kamensek U, Ota M, Tozon N, Sersa G, Cemazar M.

Cancer Gene Ther. 2018 Oct;25(9-10):260-273. doi: 10.1038/s41417-018-0014-5. Epub 2018 Mar 29.

PMID:
29593358
18.

Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases.

Gehl J, Sersa G, Matthiessen LW, Muir T, Soden D, Occhini A, Quaglino P, Curatolo P, Campana LG, Kunte C, Clover AJP, Bertino G, Farricha V, Odili J, Dahlstrom K, Benazzo M, Mir LM.

Acta Oncol. 2018 Jul;57(7):874-882. doi: 10.1080/0284186X.2018.1454602. Epub 2018 Mar 25. Review.

19.

Vascularization of the tumours affects the pharmacokinetics of bleomycin and the effectiveness of electrochemotherapy.

Groselj A, Kranjc S, Bosnjak M, Krzan M, Kosjek T, Prevc A, Cemazar M, Sersa G.

Basic Clin Pharmacol Toxicol. 2018 Sep;123(3):247-256. doi: 10.1111/bcpt.13012. Epub 2018 May 4.

PMID:
29573558
20.

Recommendations and requirements for reporting on applications of electric pulse delivery for electroporation of biological samples.

Cemazar M, Sersa G, Frey W, Miklavcic D, Teissié J.

Bioelectrochemistry. 2018 Aug;122:69-76. doi: 10.1016/j.bioelechem.2018.03.005. Epub 2018 Mar 12.

21.

Electrochemotherapy with Bleomycin of Different types of Cutaneous Tumours in a Ferret (Mustela Putorius Furo).

Racnik J, Svara T, Zadravec M, Gombac M, Cemazar M, Sersa G, Tozon N.

Radiol Oncol. 2017 Dec 7;52(1):98-104. doi: 10.1515/raon-2017-0057. eCollection 2018 Mar.

22.

Clinically Usable Interleukin 12 Plasmid without an Antibiotic Resistance Gene: Functionality and Toxicity Study in Murine Melanoma Model.

Kamensek U, Tesic N, Sersa G, Cemazar M.

Cancers (Basel). 2018 Feb 27;10(3). pii: E60. doi: 10.3390/cancers10030060.

23.

Increased permeability of blood vessels after reversible electroporation is facilitated by alterations in endothelial cell-to-cell junctions.

Markelc B, Bellard E, Sersa G, Jesenko T, Pelofy S, Teissié J, Frangez R, Rols MP, Cemazar M, Golzio M.

J Control Release. 2018 Apr 28;276:30-41. doi: 10.1016/j.jconrel.2018.02.032. Epub 2018 Feb 21.

PMID:
29476881
24.

Antitumor in situ vaccination effect of TNFα and IL-12 plasmid DNA electrotransfer in a murine melanoma model.

Kamensek U, Cemazar M, Lampreht Tratar U, Ursic K, Sersa G.

Cancer Immunol Immunother. 2018 May;67(5):785-795. doi: 10.1007/s00262-018-2133-0. Epub 2018 Feb 21.

25.

Electrochemotherapy as treatment option for hepatocellular carcinoma, a prospective pilot study.

Djokic M, Cemazar M, Popovic P, Kos B, Dezman R, Bosnjak M, Zakelj MN, Miklavcic D, Potrc S, Stabuc B, Tomazic A, Sersa G, Trotovsek B.

Eur J Surg Oncol. 2018 May;44(5):651-657. doi: 10.1016/j.ejso.2018.01.090. Epub 2018 Feb 2.

26.

Electrotransfer of Different Control Plasmids Elicits Different Antitumor Effectiveness in B16.F10 Melanoma.

Bosnjak M, Jesenko T, Kamensek U, Sersa G, Lavrencak J, Heller L, Cemazar M.

Cancers (Basel). 2018 Jan 29;10(2). pii: E37. doi: 10.3390/cancers10020037.

27.

European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results from the treatment of mucosal cancers.

Plaschke CC, Bertino G, McCaul JA, Grau JJ, de Bree R, Sersa G, Occhini A, Groselj A, Langdon C, Heuveling DA, Cemazar M, Strojan P, Leemans CR, Benazzo M, De Terlizzi F, Wessel I, Gehl J.

Eur J Cancer. 2017 Dec;87:172-181. doi: 10.1016/j.ejca.2017.10.008.

PMID:
29156298
28.

Efficiency of electrochemotherapy with reduced bleomycin dose in the treatment of nonmelanoma head and neck skin cancer: Preliminary results.

Groselj A, Bosnjak M, Strojan P, Krzan M, Cemazar M, Sersa G.

Head Neck. 2018 Jan;40(1):120-125. doi: 10.1002/hed.24991. Epub 2017 Nov 11.

PMID:
29130624
29.

Comparable effectiveness and immunomodulatory actions of oxaliplatin and cisplatin in electrochemotherapy of murine melanoma.

Ursic K, Kos S, Kamensek U, Cemazar M, Scancar J, Bucek S, Kranjc S, Staresinic B, Sersa G.

Bioelectrochemistry. 2018 Feb;119:161-171. doi: 10.1016/j.bioelechem.2017.09.009. Epub 2017 Oct 3.

PMID:
29024870
30.

In Vitro and in vivo Evaluation of Electrochemotherapy with trans-platinum Analogue trans-[PtCl2(3-Hmpy)2].

Kranjc S, Cemazar M, Sersa G, Scancar J, Grabner S.

Radiol Oncol. 2017 Sep 14;51(3):295-306. doi: 10.1515/raon-2017-0034. eCollection 2017 Sep.

31.

Effects of Electrochemotherapy with Cisplatin and Peritumoral IL-12 Gene Electrotransfer on Canine Mast Cell Tumors: a Histopathologic and Immunohistochemical Study.

Salvadori C, Svara T, Rocchigiani G, Millanta F, Pavlin D, Cemazar M, Lampreht Tratar U, Sersa G, Tozon N, Poli A.

Radiol Oncol. 2017 Sep 14;51(3):286-294. doi: 10.1515/raon-2017-0035. eCollection 2017 Sep.

32.

Addition of 2-(ethylamino)acetonitrile group to nitroxoline results in significantly improved anti-tumor activity in vitro and in vivo.

Mitrović A, Sosič I, Kos Š, Tratar UL, Breznik B, Kranjc S, Mirković B, Gobec S, Lah T, Serša G, Kos J.

Oncotarget. 2017 Jul 17;8(35):59136-59147. doi: 10.18632/oncotarget.19296. eCollection 2017 Aug 29.

33.

Predicting irreversible electroporation-induced tissue damage by means of magnetic resonance electrical impedance tomography.

Kranjc M, Kranjc S, Bajd F, Serša G, Serša I, Miklavčič D.

Sci Rep. 2017 Sep 4;7(1):10323. doi: 10.1038/s41598-017-10846-5.

34.

Histopathological findings in colorectal liver metastases after electrochemotherapy.

Gasljevic G, Edhemovic I, Cemazar M, Brecelj E, Gadzijev EM, Music MM, Sersa G.

PLoS One. 2017 Jul 7;12(7):e0180709. doi: 10.1371/journal.pone.0180709. eCollection 2017.

35.

Keratin gene mutations influence the keratinocyte response to DNA damage and cytokine induced apoptosis.

Zupancic T, Sersa G, Törmä H, Lane EB, Herrmann H, Komel R, Liovic M.

Arch Dermatol Res. 2017 Sep;309(7):587-593. doi: 10.1007/s00403-017-1757-9. Epub 2017 Jun 24.

PMID:
28647894
36.

Gene Electrotransfer of Plasmid-Encoding IL-12 Recruits the M1 Macrophages and Antigen-Presenting Cells Inducing the Eradication of Aggressive B16F10 Murine Melanoma.

Lampreht Tratar U, Loiacono L, Cemazar M, Kamensek U, Fazio VM, Sersa G, Signori E.

Mediators Inflamm. 2017;2017:5285890. doi: 10.1155/2017/5285890. Epub 2017 May 16.

37.

Erratum to: Inhibition of the Innate Immune Receptors for Foreign DNA Sensing Improves Transfection Efficiency of Gene Electrotransfer in Melanoma B16F10 Cells.

Bosnjak M, Kamensek U, Sersa G, Stolfa D, Lavrencak J, Cemazar M.

J Membr Biol. 2018 Apr;251(2):187. doi: 10.1007/s00232-017-9960-3. No abstract available.

38.

Safety aspects of atmospheric pressure helium plasma jet operation on skin: In vivo study on mouse skin.

Kos S, Blagus T, Cemazar M, Filipic G, Sersa G, Cvelbar U.

PLoS One. 2017 Apr 5;12(4):e0174966. doi: 10.1371/journal.pone.0174966. eCollection 2017.

39.

Electrotransfer of plasmid DNA radiosensitizes B16F10 tumors through activation of immune response.

Savarin M, Kamensek U, Cemazar M, Heller R, Sersa G.

Radiol Oncol. 2017 Feb 22;51(1):30-39. doi: 10.1515/raon-2017-0011. eCollection 2017 Mar 1.

40.

Inhibition of the Innate Immune Receptors for Foreign DNA Sensing Improves Transfection Efficiency of Gene Electrotransfer in Melanoma B16F10 Cells.

Bosnjak M, Kamensek U, Sersa G, Stolfa D, Lavrencak J, Cemazar M.

J Membr Biol. 2018 Apr;251(2):179-185. doi: 10.1007/s00232-017-9948-z. Epub 2017 Feb 15. Erratum in: J Membr Biol. 2017 May 3;:.

41.

Gene electrotransfer into skin using noninvasive multi-electrode array for vaccination and wound healing.

Kos S, Vanvarenberg K, Dolinsek T, Cemazar M, Jelenc J, Préat V, Sersa G, Vandermeulen G.

Bioelectrochemistry. 2017 Apr;114:33-41. doi: 10.1016/j.bioelechem.2016.12.002. Epub 2016 Dec 10.

PMID:
28006672
42.

Tailor-made fibroblast-specific and antibiotic-free interleukin 12 plasmid for gene electrotransfer-mediated cancer immunotherapy.

Kamensek U, Tesic N, Sersa G, Kos S, Cemazar M.

Plasmid. 2017 Jan;89:9-15. doi: 10.1016/j.plasmid.2016.11.004. Epub 2016 Nov 24.

PMID:
27890562
43.

Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats.

Tozon N, Lampreht Tratar U, Znidar K, Sersa G, Teissie J, Cemazar M.

J Vis Exp. 2016 Oct 24;(116). doi: 10.3791/54760.

44.

Electrochemotherapy as a single or adjuvant treatment to surgery of cutaneous sarcoid tumours in horses: a 31-case retrospective study.

Tozon N, Kramaric P, Kos Kadunc V, Sersa G, Cemazar M.

Vet Rec. 2016 Dec 17;179(24):627. doi: 10.1136/vr.103867. Epub 2016 Oct 7.

PMID:
27758950
45.

Electrochemotherapy with bleomycin is effective in BRAF mutated melanoma cells and interacts with BRAF inhibitors.

Dolinsek T, Prosen L, Cemazar M, Potocnik T, Sersa G.

Radiol Oncol. 2016 Jul 19;50(3):274-9. doi: 10.1515/raon-2016-0042. eCollection 2016 Sep 1.

46.

Identification and quantification of bleomycin in serum and tumor tissue by liquid chromatography coupled to high resolution mass spectrometry.

Kosjek T, Krajnc A, Gornik T, Zigon D, Groselj A, Sersa G, Cemazar M.

Talanta. 2016 Nov 1;160:164-171. doi: 10.1016/j.talanta.2016.06.062. Epub 2016 Jun 28.

PMID:
27591601
47.

Electrotransfer parameters as a tool for controlled and targeted gene expression in skin.

Kos S, Blagus T, Cemazar M, Lampreht Tratar U, Stimac M, Prosen L, Dolinsek T, Kamensek U, Kranjc S, Steinstraesser L, Vandermeulen G, Préat V, Sersa G.

Mol Ther Nucleic Acids. 2016 Aug 30;5(8):e356. doi: 10.1038/mtna.2016.65.

48.

Bystander Effect Induced by Electroporation is Possibly Mediated by Microvesicles and Dependent on Pulse Amplitude, Repetition Frequency and Cell Type.

Prevc A, Bedina Zavec A, Cemazar M, Kloboves-Prevodnik V, Stimac M, Todorovic V, Strojan P, Sersa G.

J Membr Biol. 2016 Oct;249(5):703-711. Epub 2016 Jul 1.

PMID:
27371159
49.

European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results of the treatment of skin cancer.

Bertino G, Sersa G, De Terlizzi F, Occhini A, Plaschke CC, Groselj A, Langdon C, Grau JJ, McCaul JA, Heuveling D, Cemazar M, Strojan P, de Bree R, Leemans CR, Wessel I, Gehl J, Benazzo M.

Eur J Cancer. 2016 Aug;63:41-52. doi: 10.1016/j.ejca.2016.05.001. Epub 2016 Jun 4.

50.

Tumor radiosensitization by gene therapy against endoglin.

Stimac M, Kamensek U, Cemazar M, Kranjc S, Coer A, Sersa G.

Cancer Gene Ther. 2016 Jul;23(7):214-20. doi: 10.1038/cgt.2016.20. Epub 2016 May 20.

PMID:
27199221

Supplemental Content

Support Center